基于UPLC/Q-TOF-MS分析附子半夏配伍相反的物质基础

利用超高效液相色谱-飞行时间质谱联用技术(UPLC/Q-TOF-MS)分析附子半夏药对配伍相反的物质基础,从化学成分层次阐释其配伍相反机制.基于UPLC/Q-TOF-MS建立附子半夏药对配伍后生物碱类成分的化学指纹图谱,通过主成分分析法和正交偏最小二乘判别法分析药对配伍在合煎过程中的生物碱类成分的含量变化,找出差异变化显著的化学成分.结果表明正离子模式时附子半夏药对合煎液中次乌头碱,中乌头碱,乌头碱,去氧乌头碱,10-OH-中乌头碱,10-OH-乌头碱等的含量明显增高,而中乌头原碱,去乙酸中乌头原碱,去乙酸次乌头原碱,苯甲酰乌头原碱,苯甲酰次乌头原碱,10-OH-苯甲酰中乌头原碱等含量降低.附子半夏药对配伍应用时双酯型二萜生物碱的含量明显增高,而单酯型二萜生物碱的含量明显降低,这可能是附子半夏药对配伍相反作用的物质基础.     

复方乌头汤配伍贝母化学成分变化研究

将超高效液相色谱-质谱联用(UPLC-MS) 及UPLC-MSⁿ技术与偏最小二乘法判别分析(PLS-DA)结合, 对乌头汤分别与川贝、 浙贝按照制川乌与贝母生药质量比1: 1配伍前后化学成分的变化情况进行了研究. 在PLS-DA模型中, 乌头汤与川贝、 浙贝配伍前后的煎煮液均可明显区分. 乌头汤与川贝共煎后获得8个化学标志物, 可鉴定出7个化合物, 其中尼奥灵、 附子灵及苯甲酰基新乌头原碱在共煎后含量上升, 塔拉定、 10-OH苯甲酰基乌头原碱、 10-OH苯甲酰基新乌头原碱和苯甲酰基去氧乌头原碱在配伍后含量下降. 乌头汤与浙贝共煎后获得7个化学标志物, 分别为Chuanfumine、 Songorine、 塔拉定、 尼奥灵、 附子灵、 苯甲酰基新乌头原碱和10-OH苯甲酰基新乌头原碱, 所有化学标志物的含量在共煎后均降低.     

电喷雾串联质谱分析附子炮制中的化学成分变化

利用电喷雾质谱方法(ESI-MS)分析了附子加辅料(甘草)炮制前后水煎液中二萜类生物碱在种类和含量方面的变化,通过加入内标化合物,建立了电喷雾质谱的半定量分析方法。此方法具有快速、准确、灵敏的特点,能够更加全面地反映中药配伍炮制过程中多种化学成分的含量变化,并能根据电喷雾串联质谱的分析结果鉴定配伍后产生的新的化学成分,在共煎液中的次乌头碱、中乌头碱和乌头碱的相对含量分别是单煎液中的5.67%、4.05%和4.88%。通过研究附子与甘草的单煎液、共煎液以及药渣中化学成分的变化,揭示了甘草作为辅料,在炮制过程中对附子减毒作用机理。     

中药川芎和赤芍配伍规律的方法研究

提出应用HPLC-PAD-MS研究中药配伍多种化学成分的基本思路,指出应用色谱保留时间、紫外光谱及质谱等多信息、综合对照的方法确定合煎液中各峰的归属,从而进一步研究了中药的配伍规律.首先建立了一套稳定、重复而可靠的液相色谱分析方法进行分离,再用统一的分析方法对分离的色谱图进行数据处理.在HPLC-PAD-MS分析中可得到各成分的保留时间、紫外光谱和分子量信息.通过比较合煎液和单煎液中各成分的保留时间及分子量信息可确定合煎液各峰的归属,最后比较了单煎液和合煎液的化学成分变化.结果表明,川芎和赤芍配伍后有一新峰产生,同时有两个成分含量发生变化.     

人参和五灵脂配伍的无机元素含量测定

采用电感耦合等离子体发射光谱法(ICP-AES)测定了人参和五灵脂配伍的无机元素含量。结果表明，人参和五灵脂及其合煎液中的铝含量均低于人参单煎液，人参和五灵配伍可减少有害元素铝的溶出；配伍合煎液中钙、硒、钼、钴、镁、铜、锰等有益元素的含量均高于人参单煎液。     

电喷雾质谱半定量方法研究制川乌配伍后的大鼠肠内菌生物转化

利用建立的代谢前后生物碱成分的电喷雾质谱半定量分析方法,通过分析各药对共煎液经大鼠肠内菌群代谢后主要生物碱的含量变化,对制川乌与浙贝母、法半夏、白蔹分别配伍后共煎液中双酯型、单酯型及脂型生物碱的肠内菌生物转化进行了深入研究,研究结果表明,配伍后中药浙贝母增加共煎液中双酯型生物碱含量,法半夏降低共煎液中双酯型生物碱含量,而白蔹对共煎液中双酯型生物碱含量影响不大;在代谢过程中,大鼠肠内菌群能够将复方中双酯型生物碱转化为脂型生物碱,从而达到中药配伍的减毒增效目的。本文通过化学方法和肠内菌代谢研究证明了制川乌配伍及代谢的机理。     

麻黄-甘草药对配伍前后主要药效成分及抗炎活性的变化

利用高效液相色谱串联质谱联用法(HPLC-MS/MS)和气相色谱质谱联用法(GC-MS)分析了麻黄与甘草药对配伍前后水煎液中主要药效成分的变化,并通过小鼠的耳廓肿胀试验考察了甘草、麻黄单煎液及药对共煎液的抗炎活性变化.分别通过HPLC法和GC-MS法对甘草与麻黄中主要化学成分,甘草酸、甘草苷、麻黄碱和甲基麻黄碱进行了定量分析,通过单煎液和药对共煎液的对比,发现麻黄与甘草配伍共煎液中麻黄碱(含伪麻黄碱)的含量增加了14.52%;甲基麻黄碱(含甲基伪麻黄碱)的含量增加了64.0%;甘草酸含量增加了13.50%;而甘草苷含量降低了19.38%.药效实验证明,甘草与麻黄配伍后抗炎作用较甘草麻黄单煎液明显增强.从而在主要成分的变化程度上揭示了甘草与麻黄配伍过程中的增效机理.     

麻黄-甘草药对配伍过程中的主要药效成分的分析

利用高效液相色谱串联质谱联用法(HPLC-MS/MS)和气相色谱质谱联用法(GC-MS)分析了麻黄与甘草药对配伍前后水煎液中主要药效成分的变化,并通过小鼠的耳廓肿胀试验考察了甘草、麻黄单煎液及药对共煎液的抗炎活性变化。分别通过HPLC法和GC-MS法对甘草与麻黄中主要化学成分,甘草酸、甘草苷、麻黄碱和甲基麻黄碱进行了定量分析,通过单煎液和药对共煎液的对比,发现麻黄与甘草配伍共煎液中麻黄碱（含伪麻黄碱）的含量增加了14.52%;甲基麻黄碱（含甲基伪麻黄碱）的含量增加了64.0%;甘草酸含量增加了13.50%;而甘草苷含量降低了19.38%。药效实验证明,甘草与麻黄配伍后抗炎作用较甘草麻黄单煎液明显增强。从而在主要成分的变化程度上揭示了甘草与麻黄配伍过程中的增效机理。     

液相色谱指纹图谱在当归、黄芪及其复方有效成分分析中的应用

将液相色谱指纹图谱与正辛醇-水分配体系模拟中药在人体内的吸收情况相结合分析中药活性成分,分析比较了当归、黄芪单煎液及合煎液在不同靶位酸度下化学成分种类、含量的变化情况,探讨了配伍及酸度变化对中药中各成分的形态分布及在人体中吸收情况的影响.发现不同靶位环境的酸度及不同配伍对中药中的有效物质组分、含量及各组分的吸收都有很大的影响.     

超高效液相色谱-质谱结合主成分分析方法研究制川乌配伍前后的肠内菌代谢差异

利用超高效液相色谱-质谱联用( UPLC-MS)技术结合主成分分析方法研究制川乌单煎液、制川乌与白芍、制川乌与防己共煎液在大鼠肠内菌中的代谢差异。采用SIMCA-P软件,以肠内菌代谢后乌头类生物碱的相对含量为变量进行主成分( PCA)分析。在主成分得分图中,制川乌单煎液与制川乌-白芍、制川乌-防己共煎液均可以明显区分,说明制川乌单煎液与制川乌-白芍、制川乌-防己共煎液的肠内菌生物转化存在显著差异。通过主成分分析载荷图及独立样本t检验,从制川乌-白芍组得到7种差异显著的标志物,从制川乌-防己组得到6种标志物,其中制川乌-白芍组有4种标志物经肠内菌代谢后含量高于制川乌组,而制川乌-防己组有1种化合物含量高于制川乌组,两组中其它标志物含量低于制川乌组。这些标志物可能是制川乌配伍前后药效差异的物质基础。     

液质联用技术研究人参与干姜或赤芍配伍前后人参皂苷及其抗氧化活性的变化

采用高效液相色谱与电喷雾质谱联用技术(HPLC-ESI-MS),对不同质量比的人参与干姜或赤芍配伍过程中人参皂苷的变化进行了研究,发现随加入的干姜量增加,共煎液中的人参皂苷含量依次降低;少量的赤芍可以使各皂苷的溶出量增加;同时测定了人参单煎液、人参与干姜、赤芍共煎液中正丁醇提取物和水提物的抗氧化活性。 以抗坏血酸(500 μmol/L)作对照,人参与干姜、赤芍配伍溶液的抗氧化活性比人参单煎液要好,同时人参与干姜、赤芍共煎液中正丁醇提取物的FRAP(铁离子还原/抗氧化能力测定)值分别为1562.29和2969.78 μmol/L,高于人参与2种药单煎液（1260.27和2502.07 μmol/L）之和。     

高效液相色谱-飞行时间质谱联用法分析人参及人参皂苷与山楂配伍过程中的水解行为

利用高效液相色谱-飞行时间质谱联用的方法,分别对人参配伍山楂前后人参皂苷的变化进行分析,同时对人参皂苷Re、Rg1、Rb1、Rd与山楂配伍的水解规律进行系统研究,并与单独煎煮液、仿山楂配伍pH值煎煮液的水解产物进行比较,结果发现人参与山楂配伍后人参皂苷Rg1、Rb1含量明显减少,而人参皂苷Re、Rd、Rg2、Rg3、F2、Rh1含量明显增加,其中人参皂苷Re与山楂配伍后水解产物为人参皂苷20(R)-Rg2、20(S)-Rg2,仿山楂配伍pH值水解产物为人参皂苷20(R)-Rg2、20(S)-Rg2、Rg4、Rg6;人参皂苷Rg1与山楂配伍后水解产物为20(S)-Rh1、20(R)-Rh1,仿山楂pH值水解产物为20(S)-Rh1、20(R)-Rh1、Rh4、Rk3;人参皂苷Rb1与山楂配伍后水解产物为Rd、20(S)-Rg3,仿山楂pH值水解产物为F2、20(S)-Rg3;人参皂苷Rd与山楂配伍后水解产物为F2、20(S)-Rg3、20(R)-Rg3,仿山楂pH值水解产物为20(S)-Rg3、20(R)-Rg3。研究表明,不同人参皂苷和山楂配伍后与仿山楂pH值的水解产物并不相同,人参与山楂配伍改变了人参皂苷成分的种类及含量。本研究为临床方剂中人参与山楂配伍后成分的变化提供物质基础数据。     

Quality assessment of a formulated Chinese herbal decoction, Kaixinsan, by using rapid resolution liquid chromatography coupled with mass spectrometry: A chemical evaluation of different historical formulae

Kaixinsan is an ancient Chinese herbal decoction mainly prescribed for patients suffering from mental depression. This decoction was created by Sun Si-miao of Tang Dynasty (A.D. 600) in ancient China, and was composed of four herbs: Radix and Rhizome Ginseng, Radix Polygalae, Rhizoma Acori Tatarinowii and Poria. Historically, this decoction has three different formulations, each recorded at a different point in time. In this study, the chemical compositions of all three Kaixinsan formulae were analyzed. By using rapid resolution LC coupled with a diode-array detector and an ESI triple quadrupole tandem MS (QQQ-MS/MS), the Radix and Rhizome Ginseng-derived ginsenosides including Rb(1), Rd, Re, Rg(1), the Radix Polygalae-derived 3,6'-disinapoyl sucrose, the Rhizoma Acori Tatarinowii-derived α- and β-asarone and the Poria-derived pachymic acid were compared among the three different formulations. The results showed variations in the solubility of different chemicals between one formula and the others. This systematic method developed could be used for the quality assessment of this herbal decoction.     

Chemical composition differentiation of Shen‐Shuai‐Ning granule between combined decoction and separated decoction using HPLC‐DAD‐ESI‐QTOF‐MS

Shen‐Shuai‐Ning (SSN) granule, a traditional Chinese medicine formula, is widely used in clinical practice for treating chronic renal failure. However, its detailed chemical profile is unknown. Here, HPLC‐ESI‐QTOF‐MS was employed for the systematic chemical analysis of SSN. A total of 52 compounds were identified and the characteristic ions of the compounds were described. Furthermore, chemical consistency between the combined decoction and the separated decoction of SSN was evaluated using HPLC‐DAD. A chemical comparison between two preparations of SSN granule (combined decoction and separated decoction of Coptides Rhizoma) indicated a significant difference in the content of many compounds, including salvianolic acid A, salvianolic acid B, berberine, palmatine and epiberberine. As a result, separated decoction of Coptides Rhizoma would lead to a significantly decrease in depsides in Salviae Miltiorrhizae Radix et Rhizoma and an increase in alkaloids in Coptidis Rhizoma.     

Identification of bioactive compounds in Shaoyao‐Gancao decoction using β2‐adrenoceptor affinity chromatography

Shaoyao‐Gancao decoction, a Chinese herbal formula, is composed of Paeoniae Radix alba and Glycyrrhiza Radix et rhizoma . It has been widely used to treat muscle spasms and asthma. However, little is known about the bioactive components of Shaoyao‐Gancao decoction. In the present study, the bioactive compounds in water‐extract of Shaoyao‐Gancao decoction were separated by the immobilized β₂‐adrenoceptor affinity column and identified using quadrupole time‐of‐flight mass spectrometry. The affinity constants of the separated compounds that bind to β₂‐adrenoceptor were determined by frontal analysis. Compound bioactivity was tested in a rat tracheal smooth muscle relaxation assay. We identified the bioactive compounds in the water extract of Shaoyao‐Gancao decoction that bound to the β₂‐adrenoceptor as paeoniflorin and liquiritin. Paeoniflorin and liquiritin had only one binding site on the immobilized β₂‐adrenoceptor, and the affinity constants were (2.16 ± 0.10) × 10⁴ M⁻¹ and (2.95 ± 0.15) × 10⁴ M⁻¹, respectively. Both compounds induced a concentration‐dependent relaxation of tracheal smooth muscle following K⁺‐stimulated contraction, and the relaxation effects were abrogated by the β₂‐adrenoceptor antagonist, ICI 118551. Therefore, paeoniflorin and liquiritin are bioactive compounds in Shaoyao‐Gancao decoction and the β₂‐adrenoceptor affinity chromatography is a useful tool for identifying potential β₂‐adrenoceptor ligands in natural products used in traditional Chinese medicine.     

Study on the therapeutic material basis of traditional chinese medicinal preparation Suanzaoren decoction

Methodology for elucidating the therapeutic material basis and quality control indices of Traditional Chinese Medicinal Preparation Suanzaoren decoction was developed. Combination of Suanzaoren decoction was designed and sixteen groups were obtained. Effects on frequency of spontaneous motion, sleeping number and sleeping duration in mice were studied with sixteen combinations of Suanzaoren decoction to get the pharmacological data. RP-HPLC method was developed to analyze the chromatographic profiles of natural components in all combinations. Areas (corrected by weighting amounts) of chromatographic peaks were collected as chemical data. The pharmacological and chemical data were correlated by chemical statistical methods, and then the therapeutic material basis (thirteen chemical constituents with sedative and hypnotic effects among forty-eight chromatographic peaks) of Suanzaoren decoction were elucidated. Spinosin from Semen Ziziphi Spinosae, ferulic acid from Rhizoma Chuanxiong, mangiferin from Rhizoma Anemarrhenae and glycyrrhizic acid from Radix Glycyrrhizae were selected as quality control indices. This paper provided a new methodology for elucidating the therapeutic material basis and quality control indices for T.C.M. It is instructive for modernization of Chinese herbs and its compound preparations.     

固定化脂质体色谱研究中药复方的细胞膜通透性成分及其质量控制

提出了固定化脂质体色谱(immobilized liposome chromatography,ILC)研究中药复方的细胞膜通透性成分及其质量控制的方法。以当归补血汤及其组分为例,考察了它们在ILC色谱柱上的分离效果;当归补血汤水提取液和75％乙醇提取液在ILC色谱柱上各有8个保留峰,当归水提取液、甲醇提取液和75％乙醇提取液在ILC色谱柱上分别有3、6、9个保留峰,黄芪水提取液、甲醇提取液和75％乙醇提取液在ILC色谱柱上各有7个保留峰;建立了当归补血汤及其组分中阿魏酸和蒿本内酯的定量分析方法,当归补血汤水提取液和75％乙醇提取液中阿魏酸的含量分别为0．0743％和0．0688％,蒿本内酯的含量分别为0．0472％和0．457％,当归水提取液和75％乙醇提取液中阿魏酸的含量分别为0．0694％和0．0691％,蒿本内酯的含量分别为0．0781％和0．455％。